Absorption and disposition of furosemide in congestive heart failure

作者: D. Craig Brater , Ruth Seiwell , Shirley Anderson , Ann Burdette , Gregory J. Dehmer

DOI: 10.1038/KI.1982.149

关键词:

摘要: Changes in response to furosemide and other diuretics patients with congestive heart failure (CHF) could occur because of disease-induced changes absorption the drug or disposition which affect its access site action. A difference was not found bioavailability forosemide CHF compared normal volunteers, 31 +/- 12 vs. 38 20% (mean sd), respectively. Both groups showed considerable interindividual variability, though serial analyses within individuals revealed consistency. Amounts delivered into urine after an intravenous dose correlated significantly that oral implying variability is caused primarily by either group. Overall, kinetics did differ between groups. Because heterogeneity renal cardiac function among patients, we were able demonstrate correlations plasma clearance function; turn, left ventricular ejection fraction. Consequently, some had disposition, but, for most part, differences abnormal responses to, rather than changed handling diuretic.

参考文章(25)
Björn Beermann, Elisabet Dalen, Björn Lindström, Elimination of furosemide in healthy subjects and in those with renal failure Clinical Pharmacology & Therapeutics. ,vol. 22, pp. 70- 78 ,(1977) , 10.1002/CPT197722170
D E Smith, E T Lin, L Z Benet, Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metabolism and Disposition. ,vol. 8, pp. 337- 342 ,(1980)
F. Andreasen, E. Mikkelsen, Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. European Journal of Clinical Pharmacology. ,vol. 12, pp. 15- 22 ,(1977) , 10.1007/BF00561400
Bo Odlind, Björn Beermann, Renal tubular secretion and effects of furosemide Clinical Pharmacology & Therapeutics. ,vol. 27, pp. 784- 790 ,(1980) , 10.1038/CLPT.1980.111
Harold G. Boxenbaum, Sidney Riegelman, Robert M. Elashoff, Statistical estimations in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 2, pp. 123- 148 ,(1974) , 10.1007/BF01061504
J. Perez, DS Sitar, RI Ogilvie, Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema. British Journal of Clinical Pharmacology. ,vol. 9, pp. 471- 478 ,(1980) , 10.1111/J.1365-2125.1980.TB05842.X
N. L. Benowitz, W. Meister, Pharmacokinetics in Patients with Cardiac Failure Clinical Pharmacokinectics. ,vol. 1, pp. 389- 405 ,(1976) , 10.2165/00003088-197601060-00001
Ralph E. Cutler, Andrew D. Blair, Clinical Pharmacokinetics of Frusemide Clinical Pharmacokinectics. ,vol. 4, pp. 279- 296 ,(1979) , 10.2165/00003088-197904040-00002
Leslie Z. Benet, Renato L. Galeazzi, Noncompartmental Determination of the Steady‐State Volume of Distribution Journal of Pharmaceutical Sciences. ,vol. 68, pp. 1071- 1074 ,(1979) , 10.1002/JPS.2600680845